Sun Pharma Advanced Research Company Ltd sun pharma advanced research co will hold its 21st Annual General Meeting on Monday, August 10, 2026, at 04:30 P.M. IST via video conference. The meeting covers the financial year 2025-26, and shareholders must determine their eligibility by the cut-off date to participate and vote. The company has published a public notice regarding the meeting in the Financial Express on July 09, 2026, complying with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board has established Monday, August 03, 2026, as the "Cut-off Date" to determine shareholder eligibility for voting and attending the AGM. The Annual Report for FY 2025-26, which includes the Notice of the AGM, will be sent electronically to shareholders with registered email addresses and will be available on the company's website. Kajal Damania, Company Secretary and Compliance Officer, signed the intimation on July 09, 2026.

Key AGM Details

Shareholders are advised to verify and update their contact details, including email IDs and addresses, with their Depository Participants and the company's Registrar and Transfer Agent. This step is necessary to ensure the timely delivery of the Annual Report and facilitate participation in the e-voting process. The Notice of the AGM outlines specific procedures for registering or updating email and bank details, casting votes through e-voting, and attending the meeting via video conference.

Sun Pharma Advanced Research Company Limited has announced significant changes to its senior management personnel, including the retirement of its Chief Operating Officer. Dr. Nitin Dharmadhikari will retire from his position as Chief Operating Officer and member of the Senior Management Team, effective from the close of business hours on June 30, 2026. The transition marks a key shift in the operational leadership structure of the company.

Ms. Shanta Gupta, the Functional Head – Human Resources & Administration, will also retire from the services of the company effective the close of business hours on June 30, 2026. The simultaneous departure of these two senior leaders necessitated immediate succession planning to maintain continuity in the company's human resources and administrative functions.

To fill the vacancy created by Ms. Gupta's retirement, the company has appointed Mr. Prasanna Deshmukh as the new Functional Head – Human Resources & Administration. He will assume the role and be designated as Senior Management Personnel with effect from July 1, 2026. The appointment ensures a seamless handover of responsibilities within the HR division.

Mr. Deshmukh brings extensive experience to his new role, having previously served as an HR Business Partner at Sun Pharmaceutical Industries Ltd. (SPIL). His background includes partnering with the Global Quality and Compliance business unit across sites worldwide, driving people strategy aligned with regulatory standards. He holds a Master's degree in HRM & LR from the Tata Institute of Social Sciences, Mumbai.

The disclosures were made to the stock exchanges pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that all necessary details regarding the changes have been submitted to the National Stock Exchange of India Ltd. and BSE Limited.